Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Pharmaceutical Business

NEW BRUNSWICK, N.J., Oct. 11 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Oct. 19, 2010, to discuss third-quarter financial results and review its Pharmaceutical business.  The meeting will be hosted by Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group; Dominic Caruso, Vice President, Finance and Chief Financial Officer; and Louise Mehrotra, Vice President, Investor Relations.

Investors and other interested parties may access the broadcast of the live meeting by visiting the Company's website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the meeting concludes by visiting www.investor.jnj.com.

SOURCE Johnson & Johnson

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.